Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A MedlinePlus Genetics resource about multiple myeloma is listed among the study’s related topics, and the site revision identifier changes from v3.8.0 to v3.8.1.
    Difference
    0.2%
    Check dated 2026-11-17T17:21:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical-trial record for the completed short-course daratumumab study is displayed, with details on its design, participant criteria, sites, and study measures. A study protocol and statistical analysis plan are also listed.
    Difference
    50%
    Check dated 2026-11-10T16:42:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T16:53:41.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The displayed site revision changes from v3.7.0 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T17:10:52.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The study page for NCT03490344 now presents a 403 Forbidden error, making the page inaccessible; the 403 page replaces the usual study details and navigation.
    Difference
    18%
    Check dated 2026-09-22T21:58:57.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision indicator on the page now shows Revision: v3.7.0, replacing v3.6.6, signaling a platform update rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-09-15T20:18:48.000Z thumbnail image

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.